Capital Flow Monitor · Sponsors · CIK 2084851
270 Growth Partners III SPV, LP
277 PARK AVENUE, NEW YORK, NY, 10172 · 2124641649
Pooled Investment Fund / Other Investment Fund · Limited Partnership· inc. DELAWARE true 2025
Fit score
—
Offering
$25.0M
Sold
$25.0M
% sold
100.0%
Investors
2
Min investment
$100K
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-09-30 | D ·current | 506(b) | $25.0M | $25.0M | 100.0% | 2 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- N/A J.P. Morgan Growth Equity Division Holdings Inc. — Promoter, New York, NY
-
Samantha Beattie — Director, New York, NY
13 other raises
- 270 Healthcare Growth Fund I LP $113.9M of —
- 270 Healthcare Growth Fund I (LUX) SCSp-RAIF $113.9M of —
- 270 Life Sciences Private Capital Fund II (US) LP $0 of —
- 270 Life Sciences Private Capital Fund II (Cayman) LP $0 of —
- 270 Hybrid Growth Onshore Fund, LP $0 of —
- 270 Hybrid Growth Cayman Fund, LP $0 of —
- 270 Private Capital Opportunities Fund IV, LP $124.0M of —
- 270 Private Capital Fund III, LP $0 of —
- 270 Private Capital Fund III (Offshore), LP $0 of —
- 270 Private Capital Opportunities Fund II, LP $0 of —
- 270 Private Capital Opportunities Fund I, LP $1.52B of —
- 270 Private Capital Opportunities Fund I (Offshore), LP $177.4M of —
- 270 Growth Partners IV SPV, LP $391.8M of —
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.